Financing deals: 7 July 2010

Oragenics, Inc. in Tampa, Florida entered into a common stock purchase agreement with the Koski Family Limited Partnership (KFLP), the company’s largest shareholder. In the deal, Oragenics will sell KFLP 5 million shares of its common stock at $0.40 a share. KFLP will also cancel and exchange for equity a previous $1 million note it issued to the company. Oragenics makes consumer, clinical, and diagnostic biopharmaceuticals.

Oncothyreon Inc. in Seattle, Washington secured an equity financing deal with Small Cap Biotech Value, Ltd. Oncothyreon may sell up to $20 million of its common stock to Small Cap Biotech Value over a two-year period. Oncothyreon is a biotechnology company specializing in oncology products.

Adeona Pharmaceuticals, Inc. in Ann Arbor, Michigan completed an equity financing of $1 million with Seaside 88, L.P. The financing involves the sale of 1,212,121 registered shares of common stock. Adeona Pharmaceuticals develops new medicines for central nervous system diseases, including Alzheimer’s disease.